Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer (Consortium-IO)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04208958 |
|
Recruitment Status :
Recruiting
First Posted : December 23, 2019
Last Update Posted : December 4, 2020
|
Sponsor:
Vedanta Biosciences, Inc.
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Vedanta Biosciences, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2021 |
| Estimated Study Completion Date : | April 2022 |